Random pentapolymer for treatment of autoimmune diseases

作者: Ehud Marom , Shai Rubnov

DOI:

关键词:

摘要: The present invention provides a synthetic polypeptide which is random pentapolymer or salt thereof, comprising alanine, glutamic acid, lysine, tyrosine and phenylalanine, useful for the treatment of autoimmune diseases and, in particular multiple sclerosis (MS). copolymer are randomly polymerized into polypeptide, thereby forming copolymer, thereof based part on unexpected finding that novel shows oral bioavailability, an advantageous release profile when formulated depot drug delivery system synergistic activity combined with additional therapeutic agent. According to first aspect, linear phenylalanine.

参考文章(81)
Ehud Hauben, Ester Yoles, Michal Eisenbach-Schwartz, Use of poly-glu, tyr for neuroprotective therapy ,(2002)
Valentin Fulga, Michal Eisenbach-Schwartz, Sharon Bakalash, Eye-drop vaccine containing copolymer 1 for therapeutic immunization ,(2004)
Oleg Butovsky, Ruth Arnon, Jonathan Kipnis, Noga Ron, Rina Aharoni, Raya Eilam, Michal Eisenbach-Schwartz, Yaniv Ziv, Induction of neurogenesis and stem cell therapy in combination with copolymer 1 ,(2005)
Oleg Butovsky, Ester Yoles, Jonathan Kipnis, Michal Eisenbach-Schwartz, Vaccine and method for treatment of neurodegenerative diseases ,(2004)
Michelle Losman, Zhengxing Qu, Serengulam V. Govindan, Gary L. Griffiths, Hans J. Hansen, Anti-DOTA antibody ,(2002)
Ruth Arnon, Aviv Shayish, Dror Haratz, Arkady-Avi Kotlyar, Synthetic peptide copolymers for treatment and prevention of cardiovascular disorders ,(2006)
Kai W. Wucherpfennig, James Rasmussen, Eric Zanelli, Jack L. Strominger, Bei Yu, Methods and compositions for treatment of autoimmune diseases ,(2005)